HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreACR® recently urged members of the Republican and Democratic U.S. House Doctors Caucuses to reform and modernize the Medicare Access and CHIP Reauthorization Act (MACRA). Although MACRA replaced a problematic Sustainable Growth Rate formula in 2014 with the Quality Payment Program (QPP), it created significant new challenges for many physicians, especially facility-based and non-patient-facing specialists like radiologists.
The College highlighted to the lawmakers the key role radiology plays in value-based care, noting that timely imaging improves outcomes and reduces costs. ACR called on Congress to enact stable payment updates, cut administrative burden, expand Advanced Alternative Payment Model access, and fully use clinical data registries like the College’s NRDR registry. The College also urged Congress to recognize radiology’s consultative practice and important contributions to population health and care coordination.
ACR continues to collaborate with Congress to strengthen a more equitable, clinically relevant, and modernized MACRA framework.
For more information or if you have questions, contact Rebecca Spangler, ACR Senior Director of Government Affairs.
HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreACR Weighs in on NRC Standard General License Proposal
ACR supports easing NRC licensing burdens but urges limits on new SGL use, ensuring existing training standards and clarity within broader regulatory reforms.
Read moreDr. Pisano Highlights ACR AI Leadership and Builds International Connections
Etta Pisano urged global collaboration on safe, effective medical AI and highlighted ACR programs advancing AI standards and clinical trial innovation.
Read more